Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT01558843

Completed

Sodium Management in Acute Neurological Injury (SANI)

This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury
NCT01698086

Completed

Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial)

Multiple Sclerosis | Fatigue | Balance | Eye Movement
NCT03805061

Completed

Effects of Aerobic and Isokinetic Exercise in Multiple Sclerosis

Multiple Sclerosis
NCT02461069

Completed

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)

Multiple Sclerosis, Relapsing-Remitting
NCT03679806

Completed

Effects Aquatic Exercises on Balance and Hand Function in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT01766063

Completed

Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon (BetaSleep)

Multiple Sclerosis
NCT02410200

Completed

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS (FOCUS)

Multiple Sclerosis, Relapsing-Remitting
NCT02369926

Unknown

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT01511133

Completed

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

Rotavirus Infection | Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants
NCT02579681

Completed

Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012 (StarTec)

Multiple Sclerosis, Relapsing-Remitting
NCT00062972

Withdrawn

Improving Memory in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT00548405

Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two (CARE-MS II)

Multiple Sclerosis, Relapsing-Remitting
NCT01455220

Completed

The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis (Tysex)

Multiple Sclerosis
NCT01993095

Completed

FlexToBa for People With Multiple Sclerosis

Multiple Sclerosis
NCT01070836

Completed

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab (STRATIFY-2)

Relapsing Multiple Sclerosis
NCT02896179

Unknown

Virtual Reality and Robot Assisted Gait Training in Patients With Multiple Sclerosis (GE-O-VR)

Multiple Sclerosis
NCT02675413

Withdrawn

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT02769767

Unknown

Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis. (WESTEMDRB1)

Multiple Sclerosis, Relapsing-Remitting
NCT02048072

Completed

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS (ANSG)

Multiple Sclerosis | Autonomic Nervous System Dysfunction
NCT02596633

Unknown

A RCT of Telephone-supported ACT in MS

Multiple Sclerosis
NCT02614989

Unknown

MRI Guided Focused Ultrasound for Tremor in Multiple Sclerosis

Multiple Sclerosis
NCT00097331

Completed

Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT02388334

Unknown

Impact of Multiple Sclerosis From the Viewpoint of the Caregivers (AQUASEP)

Multiple Sclerosis
NCT01592474

Completed

Evaluation of Brain Atrophy in CIS Patients on Avonex

Multiple Sclerosis
NCT01142583

Completed

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis (CanTOR)

Multiple Sclerosis, Relapsing-Remitting
NCT01142466

Completed

A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone (REMAIN)

Multiple Sclerosis, Relapsing-Remitting
NCT00213135

Completed

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

Multiple Sclerosis, Relapsing-Remitting
NCT01134627

Terminated

Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)

Multiple Sclerosis, Relapsing-Remitting
NCT00292266

Completed

A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

Multiple Sclerosis, Relapsing-Remitting
NCT00228397

Completed

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT00127075

Unknown

POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis

Multiple Sclerosis
NCT01453868

Unknown

The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis (NIA)

Multiple Sclerosis, Relapsing-Remitting
NCT00030966

Completed

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT00097760

Completed

Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT00501696

Completed

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Multiple Sclerosis
NCT00004814

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis
NCT00017628

Completed

Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT03161522

Recruiting

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Gastric Adenocarcinoma | Oligometastasis | Stage IV Esophageal Cancer AJCC v7 | Stage IV Gastric Cancer AJCC v7 | Stage IV Esophageal Adenocarcinoma AJCC v7
NCT00660101

Unknown

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Adenocarcinoma of the Ovary
NCT00058214

Terminated

Perifosine in Treating Patients With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate Cancer
NCT04724590

Unknown

OPHTHALMOLOGIC EVALUATION OF RADIATION-RELATED OPTIC NEUROPATHY FOLLOWING IMAGE GUIDED INTENSITY-MODULATED RADIATION THERAPY (IMRT) FOR NASOPHARYNGEAL CARCİNOMA (ORONIN)

The Aim of Our Study is to Prospectively Evaluate the Optic Neuropathy in Nasopharynx Cancer Patients
NCT07520812

Not yet recruiting

Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis

Multiple Sclerosis | Exercise | Neurofilament Light Chain
NCT07167966

Not yet recruiting

Alzheimer's Tau Platform: Regimen A - AADvac1 (ATP)

Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's Disease
NCT07135752

Recruiting

Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination (SPAM 3)

Radiologically Isolated Syndromes; Multiple Sclerosis
NCT07083856

Recruiting

Effects of Reiki and Self-Acupressure Applications

Multiple Sclerosis
NCT06755463

Not yet recruiting

Acupressure in MS Patients (APEX-MS)

Multiple Sclerosis
NCT06845722

Recruiting

Combined Effects of Balance and Cognitive Training in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT05627739

Recruiting

A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease

Vogt-Koyanagi-Harada Disease | Mycophenolate Mofetil
NCT05290688

Not yet recruiting

Cellular microRNA Signatures in Multiple Sclerosis (SEP-MIR)

Multiple Sclerosis, Relapsing-Remitting
NCT05195320

Recruiting

Reinventing Yourself With Multiple Sclerosis (MS)

Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations